Changes to the RDTL could significantly restrict patients’ access to medicines.

On MedExpress.pl, lawyer Katarzyna Czyzewska comments on the proposed changes to the emergency access to medicinal technologies scheme (RDTL).
The new measures could have a significant impact on patients’ access to treatment. The draft also includes provisions on compassionate use, which may create new opportunities for access to medicines even before they are registered.